Why Janux Therapeutics Shares Rose 33.1% This Week

Why Janux Therapeutics Shares Rose 33.1% This Week

Source: 
Motley Fool
snippet: 
  • Janux went public with an IPO last year.
  • The company plans a second investigational new drug application later this year.
  • Janux specializes in oncology therapies.